论文信息 - Atezolizumab (A) + cobimetinib (C) + vemurafenib (V) in BRAFV600-mutant metastatic melanoma (mel): Updated safety and clinical activity. - 字舞流文

Atezolizumab (A) + cobimetinib (C) + vemurafenib (V) in BRAFV600-mutant metastatic melanoma (mel): Updated safety and clinical activity.

R. Sullivan | F. Hodi | P. Hwu | J. Infante | R. Gonzalez | K. Lewis | O. Hamid | M. Ballinger | E. Cha | J. Wallin | B. Pitcher | L. Roberts | M. Patel